APA

Jones J. R., Cairns D. A., Gregory W. M., Collett C., Pawlyn C., Sigsworth R., Striha A., Henderson R., Kaiser M. F., Jenner M., Cook G., Russell N. H., Williams C., Pratt G., Kishore B., Lindsay J., Drayson M. T., Davies F. E., Boyd K. D., Owen R. G., Jackson G. H. & Morgan G. J. (20171103). Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial. : Blood cancer journal.

Chicago

Jones J R, Cairns D A, Gregory W M, Collett C, Pawlyn C, Sigsworth R, Striha A, Henderson R, Kaiser M F, Jenner M, Cook G, Russell N H, Williams C, Pratt G, Kishore B, Lindsay J, Drayson M T, Davies F E, Boyd K D, Owen R G, Jackson G H and Morgan G J. 20171103. Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial. : Blood cancer journal.

Harvard

Jones J. R., Cairns D. A., Gregory W. M., Collett C., Pawlyn C., Sigsworth R., Striha A., Henderson R., Kaiser M. F., Jenner M., Cook G., Russell N. H., Williams C., Pratt G., Kishore B., Lindsay J., Drayson M. T., Davies F. E., Boyd K. D., Owen R. G., Jackson G. H. and Morgan G. J. (20171103). Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial. : Blood cancer journal.

MLA

Jones J R, Cairns D A, Gregory W M, Collett C, Pawlyn C, Sigsworth R, Striha A, Henderson R, Kaiser M F, Jenner M, Cook G, Russell N H, Williams C, Pratt G, Kishore B, Lindsay J, Drayson M T, Davies F E, Boyd K D, Owen R G, Jackson G H and Morgan G J. Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial. : Blood cancer journal. 20171103.